前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201902226997082684
整理番号：19A0181006
薬物標的,プロリル-tRNAシンテターゼの選択的アロステリック阻害剤の生化学的および構造的特性化【JST・京大機械翻訳】
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Drug Target, Prolyl-tRNA-synthetase
Hewitt Stephen Nakazawa
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Hewitt Stephen Nakazawa
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Dranow David M.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Dranow David M.
(Beryllium Discovery Corporation, Washington, United States)
,
Horst Benjamin G.
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Horst Benjamin G.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Abendroth Jan A.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Abendroth Jan A.
(Beryllium Discovery Corporation, Washington, United States)
,
Forte Barbara
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Hallyburton Irene
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Jansen Chimed
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Baragana Beatriz
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Choi Ryan
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Choi Ryan
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Rivas Kasey L.
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Hulverson Matthew A.
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Dumais Mitchell
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Edwards Thomas E.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Edwards Thomas E.
(Beryllium Discovery Corporation, Washington, United States)
,
Lorimer Donald D.
(Beryllium Discovery Corporation, Washington, United States)
,
Fairlamb Alan H.
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Gray David W.
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Read Kevin D.
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Lehane Adele M.
(Research School of Biology, The Australian National University, Australian Capital Territory, Australia)
,
Kirk Kiaran
(Research School of Biology, The Australian National University, Australian Capital Territory, Australia)
,
Myler Peter J.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Myler Peter J.
(Center for Infectious Disease Research, Washington, United States)
,
Myler Peter J.
(Departments of Global Health and Biomedical Informatics and Medical Education, University of Washington, Washington, United States)
,
Wernimont Amy
(Structure-guided Drug Discovery Coalition (SDDC), Structural Genomic Consortium, Ontario, Canada)
,
Walpole Chris
(Structure-guided Drug Discovery Coalition (SDDC), Structural Genomic Consortium, Ontario, Canada)
,
Stacy Robin
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Stacy Robin
(Center for Infectious Disease Research, Washington, United States)
,
Barrett Lynn K.
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Barrett Lynn K.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
,
Gilbert Ian H.
(Drug Discovery Unit (DDU), Division of Biological Chemistry and Drug Discovery, University of Dundee, United Kingdom)
,
Van Voorhis Wesley C.
(Center for Emerging and Reemerging Infectious Disease (CERID), University of Washington, Washington, United States)
,
Van Voorhis Wesley C.
(Seattle Structural Genomics Center for Infectious Disease (SSGCID), Washington, United States)
資料名：
ACS Infectious Diseases
(ACS Infectious Diseases)
巻： 3 号： 1 ページ： 34-44 発行年： 2017年
JST資料番号： W5041A ISSN： 2373-8227 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： アメリカ合衆国 (USA) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。